Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+14.1%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$19.8B
AUM Growth
+$2.97B
(+18%)
Cap. Flow
+$858M
Cap. Flow
% of AUM
4.32%
Top 10 Holdings %
Top 10 Hldgs %
22.92%
Holding
1,110
New
158
Increased
343
Reduced
427
Closed
147
Top Buys
| 1 |
lululemon athletica
LULU
|
+$190M |
| 2 |
Intel
INTC
|
+$132M |
| 3 |
Old Dominion Freight Line
ODFL
|
+$115M |
| 4 |
PayPal
PYPL
|
+$111M |
| 5 |
Mastercard
MA
|
+$111M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$318M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$191M |
| 3 |
FedEx
FDX
|
+$187M |
| 4 |
Monster Beverage
MNST
|
+$145M |
| 5 |
Target
TGT
|
+$142M |
Sector Composition
| 1 | Technology | 33.61% |
| 2 | Financials | 14.27% |
| 3 | Consumer Discretionary | 14.14% |
| 4 | Healthcare | 11.46% |
| 5 | Industrials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
iRadimed
IRMD
$928M
| $614K | ﹤0.01% |
12,939
-128
| -1% | -$6.08K |
|
802
Microvast
MVST
$932M
| $607K | ﹤0.01% |
+433,694
| New | +$607K |
|
803
ESS Tech
GWH
$20.8M
| $605K | ﹤0.01% |
+35,366
| New | +$605K |
|
804
Phibro Animal Health
PAHC
$1.67B
| $592K | ﹤0.01% |
+51,083
| New | +$592K |
|
805
Inovio Pharmaceuticals
INO
$140M
| $586K | ﹤0.01% |
95,831
| – | – |
|
806
Quanex
NX
$691M
| $584K | ﹤0.01% |
19,103
-77,662
| -80% | -$2.37M |
|
|
GPMT
807
Granite Point Mortgage Trust
GPMT
$145M
| $578K | ﹤0.01% |
+97,279
| New | +$578K |
|
808
BioCryst Pharmaceuticals
BCRX
$1.69B
| $577K | ﹤0.01% |
96,397
-373,740
| -79% | -$2.24M |
|
809
eHealth
EHTH
$124M
| $567K | ﹤0.01% |
65,060
-33,820
| -34% | -$295K |
|
810
C4 Therapeutics
CCCC
$189M
| $567K | ﹤0.01% |
100,370
-764,111
| -88% | -$4.32M |
|
811
DexCom
DXCM
$30.1B
| $565K | ﹤0.01% |
4,551
-2,984
| -40% | -$370K |
|
|
PAMT
812
PAMT CORP Common Stock
PAMT
$246M
| $564K | ﹤0.01% |
27,140
-3,918
| -13% | -$81.4K |
|
813
Prelude Therapeutics
PRLD
$67.9M
| $561K | ﹤0.01% |
131,307
-12,650
| -9% | -$54K |
|
814
Sierra Bancorp
BSRR
$409M
| $555K | ﹤0.01% |
24,592
-116
| -0.5% | -$2.62K |
|
815
Tango Therapeutics
TNGX
$710M
| $553K | ﹤0.01% |
55,814
-87,667
| -61% | -$868K |
|
816
Sangamo Therapeutics
SGMO
$158M
| $548K | ﹤0.01% |
1,008,062
+604,280
| +150% | +$328K |
|
817
Matador Resources
MTDR
$6.06B
| $547K | ﹤0.01% |
+9,626
| New | +$547K |
|
818
Southern Company
SO
$101B
| $544K | ﹤0.01% |
7,756
| – | – |
|
819
Healthpeak Properties
DOC
$12.5B
| $542K | ﹤0.01% |
27,380
-6,119
| -18% | -$121K |
|
820
CRA International
CRAI
$1.29B
| $536K | ﹤0.01% |
+5,426
| New | +$536K |
|
821
Heartland Express
HTLD
$668M
| $532K | ﹤0.01% |
+37,276
| New | +$532K |
|
|
TVRD
822
Tvardi Therapeutics, Inc. Common Stock
TVRD
$323M
| $518K | ﹤0.01% |
19,357
-20,757
| -52% | -$555K |
|
|
ONIT
823
Onity Group Inc.
ONIT
$363M
| $511K | ﹤0.01% |
16,615
-30,792
| -65% | -$947K |
|
824
Roblox
RBLX
$94.2B
| $508K | ﹤0.01% |
11,108
+390
| +4% | +$17.8K |
|
825
Hackett Group
HCKT
$578M
| $507K | ﹤0.01% |
22,271
+464
| +2% | +$10.6K |
|